Virginia PDAB

Information, updates, and engagement opportunities related to the
Prescription Drug Affordability Board (PDAB).

Statute:

Gov. Glenn Youngkin vetoed HB1724. Read the veto message.

PDAB (includes public meeting notices):

Virginia has not yet established a Prescription Drug Affordability Board. CANN tracks proposed and pending legislation in Virginia and will update this page as the state's posture changes.

Public Comments

Letters and testimony submitted regarding state PDAB activity

CANN Request to Veto Virginia PDAB Legislation

Publication date:

2/26/25

Letter urging the Virginia Governor to veto PDAB legislation, citing concerns about board structure, lack of patient protections, and potential harm to safety-net drug pricing programs.

View PDF

CANN Public Comment: Virginia HB 1724 — PDAB Establishment

Publication date:

1/13/25

Comment opposing Virginia HB 1724 to establish a PDAB, citing weak data analysis foundations, insufficient patient representation on proposed board, and negative precedents from other state boards.

View PDF

CANN Veto Request: Virginia SB 274/HB 570

Publication date:

2/26/24

Letter requesting Governor Youngkin veto Virginia SB 274/HB 570 establishing a PDAB, citing Colorado failures and threats to ADAP and independent pharmacies.

View PDF

CANN Written Testimony: Virginia HB 570 PDAB

Publication date:

1/29/24

Testimony opposing Virginia HB 570 establishing a PDAB, providing detailed analysis of other state board failures and recommending alternative drug affordability approaches.

View PDF

CANN Veto Request: Virginia SB 271/HB 483 — PDAB Establishment

Publication date:

3/2/26

Letter requesting the Governor of Virginia veto SB 271/HB 483 establishing a Prescription Drug Affordability Board as an ineffective affordability solution based on other state experiences.

View PDF